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Purpose/Objective: Phase space files (PHSP) generation is a 
time consuming procedure and further the size of PHSP make 
them difficult to work with. We present a procedure to 
generate within a few minutes a PHSP which reproduces the 
experimental PDD, by optimizing the energy spectrum that 
fits the experimental dose data with a genetic algorithm [1], 
and using the information from a previously stored full 
database of monochromatic PHSP and percentage depth dose 
(PDD ) from a specific simulated accelerator. 
Materials and Methods: Mobile and linear accelerators used 
in intraoperative electron radiotherapy (IOERT), such as LIAC, 
NOVAC 7 and VARIAN 21EX, have been simulated in detail 
with penEasy [2]. A full set of monochromatic PHSP, covering 
the accelerators energy spectrum range from 1 MeV to 14 
MeV, have been calculated and stored (100 million histories, 
48 hours running time on a 8 cores high capacity cluster). 
Each PHSP is binned in the type of particle, energy, axial 
angle and radial position. PDD in water is obtained with these 
parameterized PHSP with DPM [3] and stored as well (1 hour 
computation time on a 8 cores high capacity cluster). These 
calculations, both the PHSP and the PDD simulations for the 
monochromatic PHSP, need to be done only once. After that, 
our procedure consists of two consecutive phases. In phase 
one, by means of a genetic algorithm, an optimized energy 
spectrum which weights the relative contributions of the 
monochromatic PDD that reproduces the experimental dose 
data is generated. In phase two, the previously simulated 
PHSP are weighted by this energy spectrum to obtain the 
resulting PHSP that fits the experimental measurements. 
These two phases have to be performed for each individual 
case, taking a few minutes computation time in a single core 
(i7@2.5 GHz) PC.  
Results: The genetic algorithm performs an accurate fitting 
of the monochromatic PDD to the experimental data. Dose 
calculated from the resulting weighted PHSP are in good 
agreement with the measurements for all the accelerators 
studied, not only the PDD but also transverse dose profiles 
(figure 1). Computation time is below 3 minutes in a single 
core PC. 
 
Figure 1. Transverse dose profiles in water 
 
Conclusions: Preliminary results show that the genetic 
algorithm-based method to determine PHSP from a 
experimental PDD in water reproduces dose distributions 
measured with different accelerators, accurately enough for 
IOERT planning. The method is flexible and fast, being able 
to obtain a PHSP for any accelerator within minutes. The 
genetic program and the PHSP weighting algorithms have 
been incorporated in Radiance® [4], a treatment planning 
system for intraoperative radiation therapy developed by the 
GMV company. 
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Purpose/Objective: Radiochromic films and MOSFETs have 
been used successfully for in vivo measurements during intra-
operative electron radiation therapy (IOERT) of breast 
cancer1. At our institution, surgery of locally advanced 
and/or recurrent rectal cancer is often complemented with 
IOERT. The aim of this study was to determine the actual 
dose delivered during IOERT of rectal cancer through in vivo 
measurements using Gafchromic EBT3 films. 
Materials and Methods: In vivo measurements were 
performed during IOERT treatments in 21 patients with 
advanced or recurrent rectal cancer. Treatments were 
performed with a Varian Clinac 2100 CD conventional linear 
accelerator, adapted for IOERT with a hard docking system of 
cylindrical applicators (5 to 10 cm diameter) and bevel angles 
of 0, 15, 30 and 45°.  
A small piece of Gafchromic film (1.5 x 1.5 cm2) wrapped in a 
sterile plastic envelope was placed by the radio-oncologist on 
the irradiation surface. Film position was documented by a 
photo taken before the irradiation. The films were digitized 
and the pixel values converted to dose using a previously 
obtained calibration curve. Results were analysed using 
ImageJ and Octave. 
Results: Good agreement between measured and expected 
values (diff. ≤ 7%) was obtained when irradiation surfaces 
were nearly flat and the film was positioned near the centre 
of the applicator (9 procedures).  
The other results were analysed individually, based on 
irradiation conditions, the surface geometry and the position 
of the film relative to the applicator. Concave or irregular 
irradiation surfaces are frequent in pelvic IOERT. Haematic 
fluid build up also occurs and bevelled applicators are 
frequently used. This leads to much more complicated 
irradiation geometries than for breast IOERT. Dose 
differences between 3% and 10% were observed within a 
single piece of Gafchromic film, depending on the irradiation 
conditions (Figure 1). This 2D dose distribution yields 
valuable information, and constitutes one advantages of 
using film instead of point detectors such as MOSFETs.  
 
Conclusions: These preliminary results confirm that in vivo 
dosimetry during pelvic IOERT is possible, and potentially 
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useful for an independent verification of dosimetric data and 
tables used for manual calculations. 
These results also highlight the need for a better 
understanding of dose distributions associated with irregular 
and curved surfaces, through numerical modelling such as 
Monte Carlo calculations. Further investigation is thus 
necessary to understand these effects and to improve target 
coverage in pelvic IOERT. 
1. Ciocca M, Piazzi V, Lazzari R, et al. Real-time in vivo 
dosimetry using micro-MOSFET detectors during 
intraoperative electron beam radiation therapy in early-stage 
breast cancer. Radiother. Oncol. 2006;78(2):213-6.  
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Purpose/Objective: Design and dosimetry characteristics of a 
commercial applicator system for intraoperative radiation 
therapy (IORT) utilizing ELEKTA Precise accelerator have 
been previously reported. The system is geometrically more 
complex than the standard electron applicators used for 
external beam therapy. Moreover, the geometry is different 
from the reference conditions used in various dosimetry 
protocols. The purpose of this work is to validate the 
measured dosimetry data by Monte Carlo (MC) simulations. 
Materials and Methods: An IORT hard-docking commercial 
system (Arplay Medical) includes PMMA cones with different 
diameters and a set of secondary lead collimators. The 
telescopic device allows changing of source to surface 
distance (SSD). The inner diameters of the available cones 
are 40, 50, 60 and 80 mm. 6, 9 and 12 MeV beams from 
Elekta Precise linac are used for IORT treatments. The 
EGSnrc code package was used for MC simulation. First, the 
incident electron beam parameters (energy spectrum, FWHM) 
were adjusted to match the measured data (depth doses and 
profiles) at SSD=100 cm for 14x14 standard electron 
applicator. These parameters were then used to calculate 
depth doses, dose profiles and output factors with the IORT 
applicator system. BEAMnrc code was used to generate the 
phase-space file in a plane at the IORT cone end. This file 
was used in DOSXYZnrc code to calculate PDDs, profiles and 
output in a water phantom at SSD= 100 cm for each 
combination of cone diameter and beam energy. MC 
calculations were compared with the available set of 
measurements used in clinical practice. 
Results: The results of our Monte Carlo calculations were 
found to be in general agreement with the measurements, 
providing a promising tool for further studies of dose 
distribution calculations in IORT. For all combinations of 
energy and cone diameter, the calculated depth doses were 
within 2%/1mm agreement with the measurements and 
calculated profiles were within 3%/1mm agreement with the 
measurements. Calculated output factors were within 3% 
agreement with the measurements. 
Conclusions: The measured dosimetry data used for IORT 
calculations have been validated by MC simulations. This 
work also indicates that simulations can complement and/or 
replace experimental measurements for design improvements 
of an IORT system.  
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Purpose/Objective: Rectal cancer is the second most 
frequently treated tumour with intra-operative radiation 
therapy (IOERT) in Europe1 , the first being breast cancer. 
Due to the complex anatomy of the pelvic region, 
understanding the IOERT dose distribution is particularly 
challenging. This work was prompted by a preliminary 
attempt to perform and to interpret in vivo measurements, 
and aims to shed some light on how the irradiation geometry 
affects the dose distribution in pelvic IOERT. 
Materials and Methods: To determine the effect of irregular 
geometries on the dose distribution, a methodology using 
Gafchromic EBT3 films for 2D dose distributions 
determination, parallel to the incident beam was validated 
through comparison with water phantom measurements. 
Data of anatomical region irradiated, applicator diameter 
and bevel angle was obtained from 21 pelvic IOERT 
procedures. This data was combined with anatomical models 
and photographs taken during in vivo measurements. 
Schematic models were made of the more frequent 
irradiation scenarios in pelvic IOERT, and relevant phantom 
equivalents were constructed. The corresponding dose 
distributions were obtained, and compared to those in 
conventional irradiation geometry (flat surface, parallel to 
applicator bevel).  
Results: The most frequently used bevel angle is 45°. A 
curved (concave) irradiation surface is frequent in pelvic 
IOERT. Haematic fluid build-up is also problematic in this 
area. Applicator positioning can be challenging when none of 
the available applicators is an ideal fit for the surface to be 
irradiated. This results in air gaps caused by non-parallel 
alignment of surface and applicator edges. Additionally, the 
surface to be irradiated may have irregularities in contour as 
well.  
Concave irradiation surfaces affect the dose distribution, 
relative to the one obtained in water. Air gaps due to non 
parallel alignment of the applicator seem to have little 
influence, although the effect of a different angle of 
incidence is clearly visible. Irregularities in contour may 
create hotspots nearby, as shown by the arrow in Figure 1.  
 
Conclusions: Dose distributions in pelvic IOERT are complex, 
non-homogeneous and hard to predict. The constructed 
phantom models allow us to simulate dose distributions, with 
good visualization of the clinically relevant effects, but with 
a controlled geometry. The results obtained confirm that 
